Abstract P3-11-12: Biomarker phase neo-DDRD trial: Predicting response to neoadjuvant chemotherapy (NAC) in early breast cancer using the DNA damage repair deficiency (DDRD) assay
Research output: Contribution to journal › Meeting abstract › peer-review
Fingerprint
Dive into the research topics of 'Abstract P3-11-12: Biomarker phase neo-DDRD trial: Predicting response to neoadjuvant chemotherapy (NAC) in early breast cancer using the DNA damage repair deficiency (DDRD) assay'. Together they form a unique fingerprint.
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science